← ICICI Prudential Mutual Fund
ICICI Prudential Nifty Pharma Index Fund - Direct Plan - IDCW
Open Ended Schemes(Other Scheme - Index Funds)Very High Riskvs Nifty Pharma IndexISIN INF109KC12M7
NAV · 06-Jul-2026
₹20.0008
1M
+6.93%
6M
+13.03%
1Y (CAGR)
+16.16%
3Y (CAGR)
+23.51%
5Y (CAGR)
—
Since inception (CAGR)
+21.61%
NAV history
hover for values
Risk & SIP analytics
Q1 · TOP · 3Y in categoryVolatility (3y)
15.09%
Downside dev (3y)
10.26%
Max drawdown (3y)
-16.6%
Sharpe (3y)
1.13
SIP XIRR (3y)
+16.76%
Calendar-year returns
2023 +32.9%2024 +38.8%2025 -2.6%
Vs benchmark — Nifty 50
3y monthly · 36 months of overlapBeta
0.66
Alpha (p.a.)
+12.67%
Up capture
110.0%
Down capture
39.1%
Correlation
0.57
Fund facts
Fund managerNishit Patel · Ashwini Bharucha · Venus Ahuja
AUM₹1,302 Cr
Expense ratio0.32% · 2026-05-31
TER · AMFI officialDirect 0.50% · Regular 1.17% (2026-06-30)
Launch date25-Nov-2022
Plan typeOpen Ended · Others
Min lumpsum₹1,000
Min SIP₹1,000
Lock-inNone
Volatility14.57
AMCICICI Prudential Asset Management Company Limited
Objective · The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
scheme documents ↗